(0.08%) 5 331.75 points
(0.01%) 40 143 points
(0.13%) 18 659 points
(-0.11%) $79.97
(0.80%) $2.65
(1.05%) $2 442.80
(2.80%) $32.14
(0.25%) $1 092.70
(-0.02%) $0.920
(-0.02%) $10.67
(0.05%) $0.787
(-0.25%) $90.74
Live Chart Being Loaded With Signals
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...
Stats | |
---|---|
Today's Volume | 3.52M |
Average Volume | 148 842 |
Market Cap | 27.79B |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $0 ) 2024-08-15 |
Last Dividend | $0.0740 ( 2023-05-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | 38.06 |
ATR14 | $0.0270 (0.21%) |
Volume Correlation
Coloplast A/S Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Coloplast A/S Correlation - Currency/Commodity
Coloplast A/S Financials
Annual | 2023 |
Revenue: | $24.50B |
Gross Profit: | $16.33B (66.64 %) |
EPS: | $22.21 |
FY | 2023 |
Revenue: | $24.50B |
Gross Profit: | $16.33B (66.64 %) |
EPS: | $22.21 |
FY | 2022 |
Revenue: | $22.58B |
Gross Profit: | $15.53B (68.78 %) |
EPS: | $22.15 |
FY | 2021 |
Revenue: | $19.43B |
Gross Profit: | $13.31B (68.53 %) |
EPS: | $2.27 |
Financial Reports:
No articles found.
Coloplast A/S Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.210 (N/A) |
$0 (N/A) |
$0.0740 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0810 | 2021-05-14 |
Last Dividend | $0.0740 | 2023-05-19 |
Next Dividend | $0 | N/A |
Payout Date | 2023-05-30 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | $0.649 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.96 | -- |
Div. Sustainability Score | 7.04 | |
Div.Growth Potential Score | 5.68 | |
Div. Directional Score | 6.36 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PEGRY | Ex Dividend Junior | 2023-07-20 | Semi-Annually | 0 | 0.00% | |
CODQL | Ex Dividend Junior | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
VONOY | No Dividend Player | 2023-05-26 | Annually | 0 | 0.00% | |
ITJTY | Ex Dividend Junior | 2023-10-31 | Annually | 0 | 0.00% | |
APNHY | Ex Dividend Junior | 2023-09-21 | Sporadic | 0 | 0.00% | |
RWCB | Ex Dividend Knight | 2023-07-28 | Quarterly | 0 | 0.00% | |
DYNE | No Dividend Player | 2023-07-26 | Sporadic | 0 | 0.00% | |
LGRDY | Ex Dividend Knight | 2023-05-31 | Annually | 0 | 0.00% | |
BKKPF | Ex Dividend Junior | 2023-09-06 | Annually | 0 | 0.00% | |
SPKKY | Ex Dividend Knight | 2023-09-14 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.195 | 1.500 | 6.11 | 9.16 | [0 - 0.5] |
returnOnAssetsTTM | 0.103 | 1.200 | 6.56 | 7.87 | [0 - 0.3] |
returnOnEquityTTM | 0.360 | 1.500 | 7.11 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.938 | -1.000 | 0.620 | -0.620 | [0 - 1] |
currentRatioTTM | 0.600 | 0.800 | -1.998 | -1.598 | [1 - 3] |
quickRatioTTM | 0.370 | 0.800 | -2.53 | -2.02 | [0.8 - 2.5] |
cashRatioTTM | 0.0514 | 1.500 | -0.826 | -1.239 | [0.2 - 2] |
debtRatioTTM | 0.509 | -1.500 | 1.515 | -2.27 | [0 - 0.6] |
interestCoverageTTM | 9.89 | 1.000 | 7.45 | 7.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.014 | 2.00 | 9.66 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.469 | 2.00 | 9.77 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.513 | -1.500 | 3.95 | -5.92 | [0 - 2.5] |
grossProfitMarginTTM | 0.671 | 1.000 | 2.14 | 2.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.272 | 1.000 | 6.55 | 6.55 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0929 | 1.000 | -0.595 | -0.595 | [0.2 - 2] |
assetTurnoverTTM | 0.530 | 0.800 | 9.80 | 7.84 | [0.5 - 2] |
Total Score | 7.04 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.98 | 1.000 | 6.16 | 0 | [1 - 100] |
returnOnEquityTTM | 0.360 | 2.50 | 8.14 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.469 | 2.00 | 9.84 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.0512 | 1.500 | 8.72 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.014 | 2.00 | 9.66 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.938 | 1.500 | 0.620 | -0.620 | [0 - 1] |
pegRatioTTM | 0.692 | 1.500 | 8.72 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0892 | 1.000 | -0.269 | 0 | [0.1 - 0.5] |
Total Score | 5.68 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators